J

Jagadevareddy

Active Director Director DIN 11103591
DIN 11103591 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jagadevareddy

Data last updated:

Jagadevareddy is a Director at Krionj Clinical Research Services Private Limited (since 2025) and Designated Partner at Abhiyanthrana It Solutions Llp (since 2025).

DIN 11103591
Primary Designation Director
First Appointment 13 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jul 20252025Active
Designated Partner13 May 20252025Active

Board colleagues of Jagadevareddy

Directorship timeline

Open interactive timeline →
Krionj Clinical Research Services Private Limited
Abhiyanthrana It Solutions Llp
Premium access

Shareholding and investment profile for Jagadevareddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jagadevareddy

Jagadevareddy currently holds 2 directorships: Krionj Clinical Research Services Private Limited (Director, since 23 Jul 2025); Abhiyanthrana It Solutions Llp (Designated Partner, since 13 May 2025).

Jagadevareddy was first appointed on 13 May 2025 as Designated Partner at Abhiyanthrana It Solutions Llp.

The current boards of Jagadevareddy's companies include Lokesh Sanem (Krionj Clinical Research Services Private Limited), Uppalli Jagadeesh Sujan (Abhiyanthrana It Solutions Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available